Zevra Therapeutics will present new real-world data on arimoclomol in Niemann-Pick disease type C at SSIEM 2026. Two posters are scheduled for an Aug. 26 poster

BWB News TV • 2026-08-25 11:47 UTC • By Billy Odell Tucker-Robinson

Zevra Therapeutics will present new real-world data on arimoclomol in Niemann-Pick disease type C at SSIEM 2026. Two posters are scheduled for an Aug. 26 poster walk, adding fresh clinical evidence in a closely watched rare-disease market.

Share this article

𝕏 X / Twitter Facebook LinkedIn WhatsApp

📚 More from Billy’s World

📰 Banking With Billy News All breaking financial news & market analysis 📚 Banking With Billy Books Deep-dive books on every financial story 💬 Join the Community discord.gg/VHxwmR5j4Y 🎥 Banking With Billy on YouTube Live streams & market commentary

Banking With Billy News Network — bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y • YouTube: @BankingWithBilly